Flagship Harbor Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
|
|||||
|
2025
Q1 | $1.43M | Sell |
|
|||||
|
2024
Q4 | $1.64M | Buy |
|
|||||
|
2024
Q3 | $914K | Buy |
|
|||||
|
2024
Q1 | $650K | Buy |
|
|||||
|
2023
Q4 | $555K | Buy |
|
|||||
|
2023
Q3 | $434K | Buy |
|
|||||
|
2023
Q2 | $446K | Sell |
|
|||||
|
2023
Q1 | $491K | Sell |
|
|||||
|
2022
Q4 | $552K | Sell |
|
|||||
|
2022
Q3 | $541K | Sell |
|
|||||
|
2022
Q2 | $557K | Buy |
|
|||||
|
2022
Q1 | $553K | Buy |
|
|||||
|
2021
Q4 | $605K | Sell |
|
|||||
|
2021
Q3 | $797K | Hold |
|
|||||
|
2021
Q2 | $797K | Buy |
|
|||||
|
2021
Q1 | $790K | Buy |
|
|||||
|
2020
Q4 | $656K | Sell |
|
|||||
|
2020
Q3 | $1.73M | Buy |
|
|||||
|
2020
Q2 | $1.46M | Buy |
|
|||||
|
2020
Q1 | $464K | Buy |
|
|||||
|
2019
Q4 | $320K | Sell |
|
|||||
|
2019
Q3 | $281K | Sell |
|
|||||
|
2019
Q2 | $360K | Sell |
|
|||||
|
2019
Q1 | $570K | Buy |
|
|||||
|
2018
Q4 | $428K | Sell |
|
|||||
|
2018
Q3 | $570K | Buy |
|
|||||
|
2018
Q2 | $547K | Sell |
|
|||||
|
2018
Q1 | $494K | Buy |
|
|||||
|
2017
Q4 | $484K | Sell |
|
|||||
|
2017
Q3 | $516K | Sell |
|
|||||
|
2017
Q2 | $462K | Sell |
|
|||||
|
2017
Q1 | $403K | Sell |
|
|||||
|
2016
Q4 | $384K | Buy |
|